Citius Pharmaceuticals, Inc. (CTXR) income statement
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.51−0.01 (-1.56%)
Close on Nov 18, 2026Market cap $14.02MP/E –Yield –
Citius Pharmaceuticals, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.84
- Debt to equity
- 4.60
- Debt to assets
- 215.4%
- Cash to current liabilities
- 32.9%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.21
- Dividend yield
- –
See a number that looks wrong?